CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 109, Issue 5, Pages 1723-1730
Publisher
Wiley
Online
2018-03-09
DOI
10.1111/cas.13565
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma
- (2016) Koji Ohnishi et al. CANCER SCIENCE
- Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis
- (2016) Omar Abdel-Rahman et al. Future Oncology
- Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain–Barré syndrome: a case report
- (2016) Ryota Tanaka et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
- (2016) Christophe Massard et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer
- (2016) Tanya J. Williams et al. JAMA Neurology
- Immune responses to human cancer stem-like cells/cancer-initiating cells
- (2015) Yoshihiko Hirohashi et al. CANCER SCIENCE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma
- (2015) Y. Saito et al. Cancer Immunology Research
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma
- (2013) Koji Ohnishi et al. CANCER SCIENCE
- Clinical significance of macrophage heterogeneity in human malignant tumors
- (2013) Yoshihiro Komohara et al. CANCER SCIENCE
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles
- (2012) Z. Garcia et al. BLOOD
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD169+ macrophages at the crossroads of antigen presentation
- (2011) Luisa Martinez-Pomares et al. TRENDS IN IMMUNOLOGY
- Macrophage Expression of Hypoxia-Inducible Factor-1 Suppresses T-Cell Function and Promotes Tumor Progression
- (2010) A. L. Doedens et al. CANCER RESEARCH
- CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated Antigens
- (2010) Kenichi Asano et al. IMMUNITY
- An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
- (2009) Per-Uno Malmström et al. EUROPEAN UROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More